You are here

Article Text

Article menu
Download PDFPDF
Renal medicine
Splenic artery aneurysm: a rare complication of autosomal dominant polycystic kidney disease
  1. Nageen Anwar1,
  2. Anna Reynolds2 and
  3. Noshaba Naz2
  1. 1 Renal, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK
  2. 2 Renal, Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK
  1. Correspondence to Dr Nageen Anwar; nageeen.anwar{at}gmail.com

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is an important cause of renal dysfunction. It is the most common genetic disorder leading to end-stage kidney disease requiring dialysis. ADPKD is a multisystem disease and is linked to several extra renal abnormalities. Splenic artery aneurysms are rare in the general population. ADPKD is associated with cerebral artery aneurysms. However, splenic artery aneurysms are not a well-recognised complication of ADPKD. We report an unusual case of a splenic artery aneurysm found incidentally on abdominal CT imaging of a woman with known ADPKD.

  • Renal system
  • Arteries

https://doi.org/10.1136/bcr-2023-258601

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors All authors were responsible for drafting of the text, sourcing, and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content. NN gave final approval of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.